Additional Study Information: The primary objective of this exploratory study is to compare the change in renal function from baseline to 12 months post liver transplantation, in subjects maintained on an everolimus conversion regimen versus those maintained on a standard tacrolimus based regimen. The study consists of a screening period that must take place up to 90 days prior to, or within 10 days post liver transplantation. Participants will be randomized at baseline visit to either an everolimus conversion arm or the standard immunosuppression arm.